ADHD is one of the most heritable psychiatric conditions known, with twin studies consistently estimating that genetic factors account for roughly 74 to 88 percent of the variation in whether someone develops it. That puts ADHD’s heritability on par with height and well above most other behavioral traits. But the genetics behind it are not simple: no single “ADHD gene” has been found. Instead, ADHD arises from a combination of many common genetic variants, each nudging risk by a tiny amount, plus rarer mutations that carry somewhat larger effects in a minority of cases.
What Twin and Adoption Studies Reveal
The strongest evidence for ADHD’s genetic basis comes from comparing identical twins (who share all their DNA) with fraternal twins (who share about half). When one identical twin has ADHD, the other is far more likely to have it than when one fraternal twin does. A large analysis of clinically diagnosed ADHD across the lifespan found heritability of about 0.88 overall, with adult ADHD showing a still-substantial heritability of about 0.72.1PubMed Central. The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan A widely cited pooled estimate across multiple twin studies puts the figure at around 74 percent.2PubMed Central. Genetics of attention deficit hyperactivity disorder The range depends on how ADHD is measured — clinical diagnosis versus rating-scale symptoms, children versus adults — but the overall picture is consistent: genes matter a lot.
Adoption studies support this from a different angle. Research using the Norwegian Mother, Father and Child Cohort found that biological mothers’ ADHD traits predicted their children’s ADHD traits in a way consistent with genetic transmission. When adoptive mothers also showed an association with child ADHD, the researchers pointed out that this could reflect reverse causation — a hyperactive child might make any caregiver appear more scattered — rather than a true environmental pathway. Because a child’s behavior cannot change a biological parent’s DNA, genetic-transmission designs can rule out that kind of confounding.3Molecular Psychiatry. Genetic nurture versus genetic transmission of risk for ADHD traits in the Norwegian Mother, Father and Child Cohort Study
One point worth emphasizing: in most twin studies, the “shared environment” — factors siblings experience in common, like household income or neighborhood — explains very little of the variation in ADHD once genetics are accounted for. That does not mean environment is irrelevant (more on that below), but it does mean the family-level factors people tend to blame, like screen time or parenting style, probably play a smaller role than most assume.
Many Genes, Small Effects
ADHD is what geneticists call polygenic. Rather than one or two genes driving the condition, hundreds or even thousands of common DNA variants each contribute a tiny sliver of risk. A major genome-wide association study combining data from over 38,000 people with ADHD and nearly 187,000 controls identified 27 regions of the genome that reached statistical significance, highlighting 76 potential risk genes. Many of those genes are most active during early brain development.4PubMed Central. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains But even all 27 of those regions together explain only a fraction of the total genetic risk. Countless other variants, each too small to detect individually, likely fill in the rest.
There is a telling gap between the heritability estimated from twin studies (around 74 percent) and the heritability captured by common gene variants identified so far (roughly 22 percent).5PubMed Central. Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential This “missing heritability” is a familiar problem across psychiatry and complex diseases. Some of it likely hides in rare variants, in gene-by-gene interactions, or in regions of the genome that current tools do not capture well. As study sizes grow — the 27-loci study is already far larger than earlier efforts that found only 12 loci — more of the picture should come into focus.
The Dopamine Story and Why It Got Complicated
Early gene-hunting efforts in ADHD were guided by a straightforward idea: stimulant medications like methylphenidate work largely through the dopamine system, so genes involved in dopamine signaling should be good places to look. That reasoning paid off initially. Variants of the dopamine receptor gene DRD4 and the dopamine transporter gene DAT1 were among the first robustly linked to ADHD, and studies confirmed associations with DRD5 as well.6PubMed. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5
But genome-wide scans — which search the whole genome without assuming where to look — complicated the picture. The effects of DRD4 and DAT1 turned out to be quite small and did not always replicate in larger datasets. Meanwhile, the genome-wide scans did not turn up additional single genes with large effects, either.7PubMed Central. DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics Dopamine is still thought to be part of the story, but ADHD genetics clearly extends well beyond any one neurotransmitter pathway. The 76 potential risk genes from the latest large study implicate brain development broadly, not just dopamine circuits.
Rare Mutations That Carry Heavier Weight
Alongside the many common variants of small effect, a minority of people with ADHD carry rarer genetic changes that individually have larger consequences. These include copy number variants (CNVs) — chunks of DNA that are deleted or duplicated. A genome-wide analysis published in The Lancet found that children with ADHD had a higher rate of large, rare CNVs than controls, and when parental DNA was available, some of these turned out to be de novo, meaning they were not inherited from either parent at all.8The Lancet. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis Further work has supported the idea that de novo CNVs contribute to ADHD risk, though they account for only a small proportion of cases overall.9PubMed Central. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder
Some of these rare variants overlap with those seen in autism and other neurodevelopmental conditions. For instance, deletions and duplications at certain chromosomal regions such as 22q11.2 and 16p11.2 have been found at elevated rates in children with both ADHD and autism spectrum disorder.10PubMed Central. Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders That overlap hints at shared biological pathways across conditions rather than cleanly separate genetic architectures.
The exome-sequencing arm of the large 27-loci study found an increased burden of rare protein-truncating variants — mutations that effectively break a gene — in people with ADHD, concentrated among the same genes flagged by common-variant signals.4PubMed Central. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains This convergence, where both common tweaks and rare disruptions point to the same genes, strengthens confidence that those genes genuinely matter for ADHD biology.
Does It Matter Which Parent Has ADHD?
Intuitively, you might expect that inheriting ADHD-related genes from your mother or your father would be interchangeable. The evidence is more interesting than that. An analysis of candidate gene transmission found a systematic pattern: at nine ADHD-linked genes, the odds ratio for transmission from fathers was about 2, compared with about 1.3 for maternal transmission. Transmission to daughters, from either parent, was stronger than transmission to sons.11The American Journal of Human Genetics. Preferential Transmission of Paternal Alleles at Risk Genes in Attention-Deficit/Hyperactivity Disorder The reasons are not fully worked out; genomic imprinting — where the same gene behaves differently depending on which parent it came from — is one plausible explanation.
Paternal and maternal ADHD also appear to affect children’s cognitive profiles differently. One study found that while both parents’ ADHD predicted ADHD in their children equally well at a symptom level, paternal ADHD was associated with poorer time estimation and lower verbal IQ in daughters, while maternal ADHD was associated with weaker impulse control and motor regulation in offspring regardless of sex.12PubMed. Parent-of-origin effects in ADHD: distinct influences of paternal and maternal ADHD on neuropsychological functioning in offspring These subtle differences suggest that the route through which ADHD genes arrive may shape which brain networks are most affected, even if the headline diagnosis looks the same.
Why Boys Get Diagnosed More Often Than Girls
ADHD is diagnosed two to three times more often in boys than girls during childhood, and researchers have debated whether that gap reflects a genuine biological sex difference or a mix of diagnostic bias and differences in symptom expression. A “female protective effect” model proposes that girls need a higher genetic loading to develop ADHD, which would predict that female cases carry more risk variants and that their relatives are at elevated risk. There is some family-study evidence consistent with this: cotwins of female probands tended to have higher ADHD trait scores than cotwins of male probands across two large twin samples.13PubMed Central. Is There a Female Protective Effect Against Attention-Deficit/Hyperactivity Disorder? Evidence From Two Representative Twin Samples
However, when researchers have looked directly at common genetic variants, rare CNVs, and ultra-rare mutations, they have not found strong evidence that females with ADHD carry a meaningfully heavier genetic burden than males with ADHD. A review in The Lancet Psychiatry concluded that observed sex differences in ADHD prevalence might be better explained by recognition and referral biases — girls tend to show more inattentive and fewer hyperactive symptoms, making them less likely to be flagged by teachers and parents — rather than by large sex-based differences in the underlying genetics.14The Lancet Psychiatry. Why are females less likely to be diagnosed with ADHD in childhood than males? One population-based study found that among people clinically diagnosed with anxiety or depression, females had higher ADHD polygenic risk scores than males, but this sex difference vanished when ADHD itself was the diagnosis.15PubMed Central. Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population That pattern is consistent with the idea that genetic risk for ADHD in women sometimes manifests as mood and anxiety symptoms rather than as a textbook ADHD presentation, contributing to underdiagnosis.
When Environment and Genes Interact
Saying ADHD is 74 percent heritable does not mean 74 percent of a given person’s ADHD comes from genes and 26 percent from the environment. Heritability is a population-level statistic about variation across people. In practice, genes and environment can multiply each other’s effects. One well-studied example is prenatal tobacco exposure. A case-control study found that children who carried a specific variant in the ADRA2A gene (which affects norepinephrine signaling) and whose mothers smoked during pregnancy had a substantially higher risk of ADHD than children with either the gene variant alone or the tobacco exposure alone.16PubMed Central. Prenatal Tobacco Exposure Modulated the Association of Genetic variants with Diagnosed ADHD and its symptom domain in children: A Community Based Case–Control Study Other prenatal exposures, including alcohol and certain environmental toxins, are under investigation for similar gene-by-environment interactions, though the evidence for most of them is still early.
Epigenetic changes — chemical modifications to DNA or the proteins it wraps around, which turn genes up or down without changing the DNA sequence itself — are another bridge between genes and environment. Prenatal stress, nutrition, and toxin exposures can alter these marks, potentially influencing ADHD-related gene expression. Research in this area is still working to separate correlation from causation, and most findings are from small studies. But the concept helps explain why identical twins who share all their DNA do not always share an ADHD diagnosis: their epigenetic profiles can diverge, especially if they experienced different environments in the womb or early life.
Genetic Overlap With Other Conditions
ADHD rarely travels alone. People with ADHD are more likely to experience depression, anxiety, substance use problems, and obesity, and a growing body of genetic evidence suggests these co-occurrences are not coincidental. ADHD shares substantial genetic overlap with major depression and bipolar disorder; one analysis modeled a latent genetic factor capturing shared liability across all three conditions.17PubMed Central. Dissecting the shared genetic architecture of bipolar disorder, major depressive disorder, and attention-deficit hyperactivity disorder
The connection with obesity is particularly well documented at the genetic level. A polygenic risk score for higher body mass index predicted both inattention and hyperactivity symptoms in children, and conversely, a polygenic score for ADHD predicted higher BMI.18PubMed Central. The link between attention deficit hyperactivity disorder symptoms and obesity-related traits: genetic and prenatal explanations The biological link may run partly through dopamine signaling. A genome-wide analysis found that a specific dopamine-related pathway was enriched in both ADHD and obesity results, consistent with the idea that the same dopamine circuits involved in attention and impulsivity also regulate reward-driven eating.19Neuropsychopharmacology. Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
ADHD polygenic risk has also been linked to traits that are not psychiatric diagnoses in themselves — higher neuroticism, greater risk-taking tendency, lower scores on reasoning tests, and higher rates of smoking and alcohol consumption.20PubMed Central. Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurring Traits and Disorders These associations do not mean every person with ADHD will develop these problems. They reflect statistical tendencies across large populations and highlight how the same genetic architecture can influence a wide swath of behavior and health outcomes beyond the ADHD diagnosis itself.
Can a DNA Test Tell You If Your Child Will Have ADHD?
Given all we know about ADHD genetics, it is natural to wonder whether a genetic test could predict the condition before symptoms emerge. Researchers have built polygenic risk scores (PRS) for ADHD — essentially summing a person’s risk variants into a single number — and tested whether they improve prediction. A meta-analysis found that higher ADHD polygenic risk scores were associated with about 37 percent greater odds of having an ADHD diagnosis.21Journal of Psychiatric Research. Examining the impact of ADHD polygenic risk scores on ADHD and associated outcomes: A systematic review and meta-analysis That sounds meaningful in statistical terms, but in practical terms the scores explain only a small portion of who actually gets ADHD. One study found that adding a polygenic risk score to standard symptom questionnaires provided some additional diagnostic information, but the improvement was too modest to be clinically useful on its own.22PubMed Central. Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder
The bottom line for families: no commercially available genetic test can reliably diagnose or rule out ADHD. Diagnosis still rests on behavioral assessment by a clinician. Polygenic scores are a promising research tool, and their predictive power will improve as studies grow, but they are not ready for the clinic.
Why Hasn’t Evolution Eliminated ADHD Genes?
If ADHD genes cause real difficulties in school and at work, you might expect natural selection to have weeded them out long ago. But that has not happened. Many ADHD-associated gene variants are remarkably common — some are even fixed (present in everyone) in certain populations.23PubMed. Tuning major gene variants conditioning human behavior: the anachronism of ADHD One influential idea, sometimes called the hunter-farmer hypothesis, proposes that traits like novelty seeking, quick decision-making, and high energy were advantageous in ancestral environments that rewarded rapid responses to changing conditions. In a world that now values sustained attention and sitting still for years of formal education, those same traits register as a disorder. This does not mean ADHD is “not real” — it causes genuine impairment in modern settings — but it reframes the condition as a mismatch between ancient behavioral tendencies and contemporary demands rather than as a straightforward genetic defect.
Pharmacogenomics and Medication Response
Another area where ADHD genetics intersects with daily life is medication. Stimulants like methylphenidate and amphetamines are effective for most people with ADHD, but response varies widely. Some people get dramatic symptom relief at a low dose; others get side effects and little benefit. Researchers have investigated whether genetic variation — in dopamine pathway genes, in drug-metabolism enzymes, and genome-wide — can predict who will respond best to which medication. Despite a decade of work, no single genetic variant or available pharmacogenomic test has proven clinically useful for choosing an optimal ADHD medication for a given person.24PubMed Central. Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research As with polygenic risk scores for diagnosis, pharmacogenomics for ADHD remains an active research frontier rather than a practical tool. For now, finding the right medication is still largely a process of careful trial and observation with a clinician.